These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10727674)

  • 1. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay.
    Takahashi M; Kushida K; Nagano A; Inoue T
    Clin Chim Acta; 2000 Apr; 294(1-2):67-76. PubMed ID: 10727674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures.
    Takahashi M; Naitou K; Ohishi T; Kushida K; Miura M
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):219-24. PubMed ID: 11207637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
    Nagasue K; Inaba M; Okuno S; Kitatani K; Imanishi Y; Ishimura E; Miki T; Kim M; Nishizawa Y
    Biomed Pharmacother; 2003 Mar; 57(2):98-104. PubMed ID: 12842495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
    Kushida K; Takahashi M; Kawana K; Inoue T
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.
    Srivastava AK; Mohan S; Singer FR; Baylink DJ
    Bone; 2002 Jul; 31(1):62-9. PubMed ID: 12110414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.
    Rosenquist C; Qvist P; Bjarnason N; Christiansen C
    Clin Chem; 1995 Oct; 41(10):1439-45. PubMed ID: 7586514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical validation of a new immunoradiometric assay for intact human osteocalcin.
    Minisola S; Pacitti MT; Romagnoli E; Rosso R; Carnevale V; Caravella P; Scillitani A; Dicembrino F
    Calcif Tissue Int; 1999 May; 64(5):365-9. PubMed ID: 10203410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degree of osteoporosis in patients with vertebral fracture and patients with hip fracture: relationship to incidence of vertebral fracture.
    Takahashi M; Kushida K; Naitou K
    J Bone Miner Metab; 1999; 17(3):187-94. PubMed ID: 10757678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
    Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
    J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
    Garnero P; Grimaux M; Seguin P; Delmas PD
    J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
    Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
    Bone; 1996 Sep; 19(3):291-8. PubMed ID: 8873970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female.
    Pan C; Liu X; Li T; Wang G; Sun J
    J Orthop Surg Res; 2018 Dec; 13(1):314. PubMed ID: 30526635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoradiometric assay for intact human osteocalcin(1-49) without cross-reactivity to breakdown products.
    Colford JW; Lueddecke BA; Salvati M; Hanna D; Sailer D; Khosla S; Riggs BL; Langman CB
    Clin Chem; 1999 Apr; 45(4):526-31. PubMed ID: 10102913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
    Alexandersen P; Hassager C; Riis BJ
    Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.
    Käkönen SM; Hellman J; Karp M; Laaksonen P; Obrant KJ; Väänänen HK; Lövgren T; Pettersson K
    Clin Chem; 2000 Mar; 46(3):332-7. PubMed ID: 10702519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bone turnover in postmenopause, vertebral fracture, and hip fracture using biochemical markers for bone formation and resorption.
    Takahashi M; Kushida K; Hoshino H; Ohishi T; Inoue T
    J Endocrinol Invest; 1997 Mar; 20(3):112-7. PubMed ID: 9186815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule.
    Deftos LJ; Wolfert RL; Hill CS; Burton DW
    Clin Chem; 1992 Nov; 38(11):2318-21. PubMed ID: 1385019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K; Takahashi M; Hoshino H; Kushida K
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
    J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.